Skip to Content

M G 33 (Glipizide and Metformin Hydrochloride 5 mg / 500 mg)

Pill with imprint M G 33 is Beige, Elliptical / Oval and has been identified as Glipizide and Metformin Hydrochloride 5 mg / 500 mg. It is supplied by Mylan Pharmaceuticals Inc..

Glipizide/metformin is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Glipizide/metformin 5 mg / 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M G 33

Glipizide and metformin hydrochloride 5 mg / 500 mg M G 33
Glipizide and metformin hydrochloride 5 mg / 500 mg M G 33 Front
Glipizide and metformin hydrochloride 5 mg / 500 mg M G 33 Back
Glipizide and metformin hydrochloride 5 mg / 500 mg M G 33

Glipizide and Metformin Hydrochloride

Imprint
M G 33
Strength
5 mg / 500 mg
Color
Beige
Size
17.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Antidiabetic combinations
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
00378-3133
Inactive Ingredients
croscarmellose sodium, hypromelloses, magnesium stearate, microcrystalline cellulose, polydextrose, polyethylene glycol, povidone, sodium lauryl sulfate, titanium dioxide, triacetin, ferric oxide red, ferric oxide yellow

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "M G 33"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.